US-based Neuralink has received approval to launch a new feasibility trial studying its brain implant linked with an assistive robotic arm. Founded by Elon Musk, the company said that the trial, named CONVOY, will operate with cross-enrolling from the company’s ongoing PRIME study (NCT06429735), which is being completed in the US.

Elon Musk’s brain implant company is launching a new study to test whether its wireless device can control a robotic arm.

In a post on X.com, Neuralink said it had been granted regulatory approval for "a new feasibility trial to extend BCI control using the N1 implant to an investigational assistive robotic arm," adding that it is "an important first step towards restoring not only digital freedom, but also physical freedom."

Elon Musk's brain chip company is entering its next phase of experiments: seeing if patients can move a robotic arm using their minds.

Neuralink is conducting its PRIME study, aimed at evaluating the safety of its wireless brain-computer interface and surgical robot. It is assessing the initial effect of the implant in patients with quadriplegia, a form of paralysis, to control external devices with their thoughts.

Neuralink announced the launch of a feasibility trial to explore extending the N1 implant’s capabilities to control an assistive robotic arm. The study aims to provide individuals with paralysis the ability to perform tasks like grasping and manipulating objects using only their thoughts.

Neuralink said it has received a green light for a new clinical study to test the feasibility of connecting its brain-computer interface chip with a robotic arm. | The company said it would allow severely paralyzed patients currently signed up to receive the implant through its PRIME safety trial to also cross-enroll in a new study,

Neuralink says that the study's launch is an important step towards restoring not just digital but also physical freedom.

Elon Musk’s brain-computer interface company, Neuralink Corp., said it is starting to test a technology that could allow paralyzed people to control a robotic arm.

Neuralink says it received approval in the U.S. to launch a new feasibility trial for its brain-computer interface (BCI) technology.

Elon Musk's brain implant startup said it was launching a trial to test whether patients could use the Neuralink implant to control a robot limb.